98
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Antifungal Susceptibility and Biological Characteristics of Fonsecaea monophora Causing Cerebral Phaeohyphomycosis in Jinhua, China

, , , ORCID Icon &
Pages 7187-7195 | Received 14 Aug 2023, Accepted 04 Nov 2023, Published online: 08 Nov 2023

References

  • Arcobello JT, Revankar SG. Phaeohyphomycosis. Semin Respir Crit Care Med. 2020;41(1):131–140. doi:10.1055/s-0039-3400957
  • Pouran L, Naser TM, Mohammad R, et al. Disseminated phaeohyphomycosis caused by Cyphellophora ludoviensis: a novel case report from Iran. Australas J Dermatol. 2020;61(3):250–252. doi:10.1111/ajd.13262
  • Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis. 2004;38(2):206–216. doi:10.1086/380635
  • Takei H, Goodman JC, Powell SZ. Cerebral phaeohyphomycosis caused by ladophialophora bantiana and Fonsecaea monophora: report of three cases. Clin Neuropathol. 2007;26(1):21–27. doi:10.5414/npp26021
  • Qiu Y, Zhang J, Tang Y, et al. Case report: fever- pneumonia- lymphadenectasis- osteolytic- subcutaneous nodule: disseminated chromoblastomycosis caused by phialophora. J Infect Chemother. 2019;25(12):1031–1036. doi:10.1016/j.jiac.2019.05.002
  • He Y, Zheng HL, Mei H, et al. Phaeohyphomycosis in China. Front Cell Infect Microbiol. 2022;12:895329. doi:10.3389/fcimb
  • Surash S, Tyagi A, De Hoog GS, et al. Cerebral phaeohyphomycosis caused by Fonsecaea monophora. Med Mycol. 2005;43(5):465–472. doi:10.1080/13693780500220373
  • Lim SW, Suh MK, Kang GS, et al. Molecular phylogenetics of Fonsecaea strains isolated from chromoblastomycosis patients in South Korea. Mycoses. 2011;54(5):e415–e420. doi:10.1111/j.1439-0507.2010.01937
  • Coelho RA, Brito-Santos F, Figueiredo-Carvalho MHG, et al. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil. PLoS Negl Trop Dis. 2018;12(7):e0006675. doi:10.1371/journal.pntd.0006675
  • Liu Y, Huang X, Liu H, et al. Increased virulence of albino mutant of Fonsecaea monophora in Galleria mellonella. Med Mycol. 2019;57(8):1018–1023. doi:10.1093/mmy/myz007
  • Fransisca C, He Y, Chen Z, et al. Molecular identification of chromoblastomycosis clinical isolates in Guangdong. Med Mycol. 2017;55(8):851–858. doi:10.1093/mmy/myw140
  • Ochiai H, Kawano H, Minato S, et al. Cerebral phaeohyphomycosis: case report. Neuropathology. 2012;32(2):202–206. doi:10.1111/j.1440-1789.2011.01244.x
  • Litchevski V, Goldschmidt A, Nass D, et al. Cerebral phaeohyphomycosis in an immunocompetent patient: a case report and literature summary. Clin Neurol Neurosurg. 2014;124:179–181. doi:10.1016/j.clineuro
  • Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, et al. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob Agents Chemother. 2010;54(4):1636–1638. doi:10.1128/AAC.01655-09
  • Shen Y, Jiang B, Zhang H, et al. Combination therapy for an elderly patient with chromoblastomycosis caused by Fonsecaea monophora: a case report. Ann Transl Med. 2022;10(2):114. doi:10.21037/atm-21-6119
  • Daboit TC, Magagnin CM, Heidrich D, et al. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis. Mycopathologia. 2013;176(1–2):139–144. doi:10.1007/s11046-013-9660-1
  • Al-Abdely HM, Alkhunaizi AM, Al-Tawfiq JA, et al. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol. 2005;43(1):91–95. doi:10.1080/13693780400011104
  • Tsai CJ, Loh JM, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2016;7(3):214–229. doi:10.1080/21505594.2015.1135289
  • Kaito C. Understanding of bacterial virulence using the silkworm infection model. Drug Discov Ther. 2016;10(1):30–33. doi:10.5582/ddt.2016.01020